Huile essentielle Camomille noble
Food supplement declared in France, declaration No 2017-1-294, decision dated 12 January 2017
Huile essentielle Camomille noble, from Therascience Belgium S.A, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Chamaemelum nobile 210 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- Therascience Belgium S.A
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Bottle
- Daily dose
- 2 gouttes, 3 fois par jour
- Directions for use
- sur un support neutre
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Pregnant women
Declaration 278267, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Chamaemelum nobile (L.) All. | Huile essentielle | Distillation | 210 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Chamaemelum nobile (L.) All.
Read the warning, when it applies and the studies cited
Roman Chamomile - Chamaemelum Nobile
Route of administration: Oral (Wichtl 2004; Bradley 1992)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2000; Blumenthal et al. 1998).
Sources cited by Health Canada (3)
- Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS, editors. Herbal Medicine: Complete Commission E Monographs. Boston (MA): Integrative Medicine Communications; 1998.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Huile essentielle Camomille noble LES JARDINS DE BORDEO, declared in 2022 : same declared composition
- Huile essentielle: Camomille noble Biofloral, declared in 2020 : same declared composition
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Huile essentielle Camomille noble: composition and regulation”, https://compoatlas.com/en/supplements/products/278267-huile-essentielle-camomille-noble, updated 15 November 2026.